Why Dydrogesterone API Is Emerging as a Strategic Priority in Women’s Health Pharma
Dydrogesterone API is gaining renewed attention as pharmaceutical companies sharpen their focus on women’s health, reproductive medicine, and hormone-based therapies. As a selective progestogen with a well-established clinical profile, dydrogesterone continues to hold strategic value in formulations targeting luteal support, menstrual disorders, and pregnancy-related indications. For manufacturers and procurement leaders, this trend signals more than …
Why Dydrogesterone API Is Emerging as a Strategic Priority in Women’s Health Pharma Read More »